FDA vs. Cytodyn (My views) - After Mount Sinai, D
Post# of 148166
- After Mount Sinai, Dr. Seethamraju, had fantastic results with his critical patients, the FDA’s response was to reject the evidence as anecdotal because LL was not a “antiviral” and they had other antivirals in mind. No one at the FDA understood, now there is a peer reviewed paper, and global acceptance of the MOA.
- When their antivirals were a flop and Dr. Patterson presented the reason critical patients were dying as the disease morphed into a immunological over reaction and that LL was a cure, the FDA wanted to create cocktails with their failed drugs by adding immunosuppressants.
- None of their poor cocktails were as safe or effective as LL. So what to do now? Slow LL down until some other cocktails can be tested and hopefully confirmed as effective (cocktails including an antiviral). The world was trying to do this, without our FDA’s funding. Our FDA was pissed off at Cytodyn and Dr. Patterson for having the audacity to challenge Dr. Fauci’s views which Dr. Patterson aggravated with “anecdotal’s don’t walk of ECMO machines!”
- We all know the story and the continuing missteps by the FDA. WHY would Cytodyn trust these arrogant custodians (ha!) of the general public’s well being? I am so glad they finally moved away from the FDA. Can’t wait for the initial results from the Philippines! Brazil and India will take some time but they have excellent doctors in all of these countries. India and Philippines supply the US medical system with a ton of them.
FDA please make it a huge public fight!!